Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

909 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.
Canela MD, Noppen S, Bueno O, Prota AE, Bargsten K, Sáez-Calvo G, Jimeno ML, Benkheil M, Ribatti D, Velázquez S, Camarasa MJ, Díaz JF, Steinmetz MO, Priego EM, Pérez-Pérez MJ, Liekens S. Canela MD, et al. Among authors: ribatti d. Oncotarget. 2017 Feb 28;8(9):14325-14342. doi: 10.18632/oncotarget.9527. Oncotarget. 2017. PMID: 27224920 Free PMC article.
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.
Liekens S, Bronckaers A, Belleri M, Bugatti A, Sienaert R, Ribatti D, Nico B, Gigante A, Casanova E, Opdenakker G, Pérez-Pérez MJ, Balzarini J, Presta M. Liekens S, et al. Among authors: ribatti d. Mol Cancer Ther. 2012 Apr;11(4):817-29. doi: 10.1158/1535-7163.MCT-11-0738. Epub 2012 Feb 1. Mol Cancer Ther. 2012. PMID: 22302099
Cancer associated fibroblasts in hematological malignancies.
Raffaghello L, Vacca A, Pistoia V, Ribatti D. Raffaghello L, et al. Among authors: ribatti d. Oncotarget. 2015 Feb 20;6(5):2589-603. doi: 10.18632/oncotarget.2661. Oncotarget. 2015. PMID: 25474039 Free PMC article. Review.
Marine compounds inhibit growth of multiple myeloma in vitro and in vivo.
Steiner N, Ribatti D, Willenbacher W, Jöhrer K, Kern J, Marinaccio C, Aracil M, García-Fernández LF, Gastl G, Untergasser G, Gunsilius E. Steiner N, et al. Among authors: ribatti d. Oncotarget. 2015 Apr 10;6(10):8200-9. doi: 10.18632/oncotarget.3362. Oncotarget. 2015. PMID: 25860931 Free PMC article.
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.
Lucarelli G, Galleggiante V, Rutigliano M, Sanguedolce F, Cagiano S, Bufo P, Lastilla G, Maiorano E, Ribatti D, Giglio A, Serino G, Vavallo A, Bettocchi C, Selvaggi FP, Battaglia M, Ditonno P. Lucarelli G, et al. Among authors: ribatti d. Oncotarget. 2015 May 30;6(15):13371-86. doi: 10.18632/oncotarget.3823. Oncotarget. 2015. PMID: 25945836 Free PMC article.
Tumor refractoriness to anti-VEGF therapy.
Ribatti D. Ribatti D. Oncotarget. 2016 Jul 19;7(29):46668-46677. doi: 10.18632/oncotarget.8694. Oncotarget. 2016. PMID: 27081695 Free PMC article. Review.
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue.
Longo V, Brunetti O, Gnoni A, Cascinu S, Gasparini G, Lorusso V, Ribatti D, Silvestris N. Longo V, et al. Among authors: ribatti d. Oncotarget. 2016 Sep 6;7(36):58649-58658. doi: 10.18632/oncotarget.10765. Oncotarget. 2016. PMID: 27462915 Free PMC article. Review.
909 results